Watson Pharmaceuticals (WPI +0.6%) says the European Commission has cleared its proposed...
Watson Pharmaceuticals (WPI +0.6%) says the European Commission has cleared its proposed acquisition of Swiss-based pharmaceutical company Actavis. The commission noted in its statement that "Despite significant changes in the competitive situation in some of the markets, a sufficient number of credible and strong competitors will continue to exercise a competitive constraint on the merged entity."
From other sites
Video at CNBC.com (Thu, 5:00PM)
Video at CNBC.com (Sep 21, 2015)
Video at CNBC.com (Aug 6, 2015)
Video at CNBC.com (Jul 27, 2015)
at CNBC.com (Feb 18, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs